Sarborg Ltd

Insider Reports History

Location
Grand Cayman
Signature
/s/ Mark Taylor, Executive Director of Sarborg Ltd
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarborg Ltd:

Company Role Class Num Shares Value Price $ Report Date Ownership
CONDUIT PHARMACEUTICALS INC. 10%+ Owner Common Stock 1,853,933 $83,797 $0.0452 31 Mar 2025 Direct

Insider Reports Filed by Sarborg Ltd

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CDT CONDUIT PHARMACEUTICALS INC. 31 Mar 2025 0 $0 3 10%+ Owner 07 May 2025, 17:35